银屑病关节炎患者报告身体功能结局测量工具的真实世界国际队列比较
三种工具均满足结构效度假设,PsAID-FC对变化更敏感,且单条目PsAID-FC表现与其他工具相似,可作为测量PsA特异性身体功能的额外选择。
要点
- HAQ DI和PsAID-FC分别有31%和21%的患者出现天花板效应,地板效应极小。
- 三种患者报告结局测量工具均满足结构效度的先验假设。
- PsAID-FC对变化比HAQ DI和SF-12 PCS更敏感,恶化组与无变化组的标准化反应均方比为40.1。
核心结论
- HAQ DI、SF-12 PCS和PsAID-FC均是银屑病关节炎身体功能的有效测量工具。
- 单条目PsAID-FC表现与其他患者报告结局测量工具相似,可作为测量PsA特异性身体功能的额外选择。
研究设计与样本
- 纵向研究,纳入14个国家连续成人确诊银屑病关节炎且病程≥2年的患者。
- 基线分析414例(52%男性),平均±SD年龄52.4±12.5岁,病程10.9±8.1年。
主要发现
- HAQ DI和PsAID-FC分别有31%和21%的患者出现天花板效应,地板效应极小。
- 三种患者报告结局测量工具均满足结构效度的先验假设。
- 中位随访4.1个月(四分位距2.7)的350例患者中,27%报告改善、54%无变化、18%恶化。
- 恶化组与无变化组比较,标准化反应均方比分别为HAQ DI 29.9、SF-12 PCS 16.7、PsAID-FC 40.1。
- PsAID-FC对变化比HAQ DI和SF-12 PCS更敏感。
临床怎么用
- 临床可选用HAQ DI、SF-12 PCS或PsAID-FC评估银屑病关节炎患者身体功能。
- PsAID-FC为单条目工具,对变化更敏感,可作为PsA特异性身体功能的额外测量选项。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We evaluated the psychometric properties of 3 patient-reported outcome measures to assess the physical function in psoriatic arthritis (PsA). METHODS: Data were available for the Health Assessment Questionnaire disability index (HAQ DI), the 12-item Short Form instrument physical component summary (SF-12 PCS), and the Psoriatic Arthritis Impact of Disease instrument functional capacity score (PsAID-FC). Data came from a longitudinal study in 14 countries of consecutive adults with definite PsA with ≥2 years of duration. The score distribution, construct validity, responsiveness, and thresholds of meaning of the patient-reported outcome measures were evaluated. RESULTS: At baseline, 414 subjects (52% male) were analyzed. The mean ± SD age was 52.4 ± 12.5 years and duration of illness was 10.9 ± 8.1 years. Ceiling effects were noted in 31% and 21% of patients for HAQ DI and PsAID-FC, respectively; floor effects were minimal. All 3 patient-reported outcome measures met a priori hypotheses for construct validity. After a median follow-up of 4.1 (interquartile range 2.7) months in 350 patients, 27%, 54%, and 18% of patients reported themselves improved, not changed, and worsened, respectively. Change scores were statistically different for groups for worsening versus no-change for all patient-reported outcome measures. PsAID-FC was more sensitive to change than the other 2 patient-reported outcome measures. Comparing groups with worsening condition to no-change, the standardized response mean square ratios were HAQ DI 29.9, SF-12 PCS 16.7, and PsAID-FC 40.1. CONCLUSION: HAQ DI, SF-12 PCS, and PsAID-FC are valid measures of physical function for PsA. PsAID-FC, a single question, performed similarly to the other patient-reported outcome measures and may be an additional option to measure PsA-specific physical function.
引用
- Leung YY, Orbai AM, de Wit M, et al. Comparing the Patient-Reported Physical Function Outcome Measures in a Real-Life International Cohort of Patients With Psoriatic Arthritis. Arthritis Care Res (Hoboken). 2021. PMID: 31961492. doi:10.1002/acr.24139
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。